Evidence map›Paper›PMID 25610109›Full record

ArticleThe Eurasian journal of medicine2010

Distribution of HLA Tissue Groups in Patients with Gastric Cancer.

Mehmet Bilici, Nihat Okcu, Kerim Cayır, Ibrahim Pirim, Salim B Tekin, Cemal Gundogdu

Open access · diamondAbstract read
In one paragraph

Article in The Eurasian journal of medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mehmet BiliciDepartment of Internal Medicine, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Nihat OkcuDepartment of Internal Medicine, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Kerim CayırDepartment of Internal Medicine, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Ibrahim PirimDepartment of Medical Biology, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Salim B TekinDepartment of Internal Medicine, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Cemal GundogduDepartment of Pathology, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Atatürk University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveGastric cancer is an important disease that is seen all over the world and that threats public health. At the same time, gastric cancer is a heterogeneous disorder with multifactorial etiologies. Recent studies have shown a significant association between HLA antigens and gastric adenocarcinoma. The aim of the present study was to determine the distribution of HLA class I (HLA-A, B and C) and class II (HLA-DR, DQ and DP) antigens in Turkish patients with gastric adenocarcinoma. MATERIALS AND

methodsHLA alleles or HLA haplotypes associated with gastric cancer were established in the Turkish population using PSR-SSP analysis in 71 unrelated patients with gastric cancer and in 82 unrelated healthy controls. The statistical significance of differences in allele frequencies between patients and controls was measured by the Chi-square test with Yates's correction.

resultsThe study revealed that the HLA-Cw5 antigen is more prevalent in patients with gastric cancer (p=0.042) and that the HLA-DRB1*15 antigen is more prevelent in the control group (p=0.021).

conclusionIt is probable that HLA-Cw5 is a risk factor for gastric cancer whereas HLA-DRB1*15 plays a protective role for this disease. The results show that different loci on HLA may control resistance to or tendency for any disease in different societies; each society should determine its own tissue group.

Indexed as

Gastric cancerHLA antigensHLA-Cw5HLA-DRB1*15

Identifiers

PMID25610109
PMCPMC4261300
OpenAlexW2074842268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.